1993
DOI: 10.1111/j.1365-2559.1993.tb01251.x
|View full text |Cite
|
Sign up to set email alerts
|

Gallbladder vasculitis: a report of two cases

Abstract: Singer A. Anatomy of the cervix and physiological changesof the epithelium. In Fox H ed. Hains and Taylor Obstetrical and GymmdtJgical Pathology. Edinburgh: Churchill Livingstone, 1987: 228-2 36. 4. Ulbright TM. Roth LM. Common epithelial tumours of the ovary: proliferating and of low mallgnant potential. Semin. Diag. Patllol. 1985: 2; 2-15. 5. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of Mullerian type. A clinicopathologic analysis. Cancer 1988: 61; 546-55… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 3 publications
0
15
0
Order By: Relevance
“…Mean duration of GB-related (right-upper quadrant or abdominal) symptoms was 9.5 weeks (median, 1 wk; range, 0-60 wk) prior to diagnosis. Lithiasic cholecystitis and/or chronic cholelithiasis was the clinical presentation in 44% of patients, 3,4,11,14,17,19,31,34,38,40,46,48,50,51,61 45.7% presented with acalculous cholecystitis, 1,3,5,12,16,18,20,22,23,28,32,36 -38, 42-48,51,58-60 3.4% with bile duct obstruction, 10,15 and 6.7% did not exhibit abdominal symptoms; GV was discovered because of abnormal GB findings in imaging studies, 9,38 exploratory laparotomy (current study Patient 5), or necropsy. 56 GB-related manifestations were the only expression of GV in 20 (33%) patients.…”
Section: Overall Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Mean duration of GB-related (right-upper quadrant or abdominal) symptoms was 9.5 weeks (median, 1 wk; range, 0-60 wk) prior to diagnosis. Lithiasic cholecystitis and/or chronic cholelithiasis was the clinical presentation in 44% of patients, 3,4,11,14,17,19,31,34,38,40,46,48,50,51,61 45.7% presented with acalculous cholecystitis, 1,3,5,12,16,18,20,22,23,28,32,36 -38, 42-48,51,58-60 3.4% with bile duct obstruction, 10,15 and 6.7% did not exhibit abdominal symptoms; GV was discovered because of abnormal GB findings in imaging studies, 9,38 exploratory laparotomy (current study Patient 5), or necropsy. 56 GB-related manifestations were the only expression of GV in 20 (33%) patients.…”
Section: Overall Resultsmentioning
confidence: 99%
“…9,10,12,37,46,54 GB-SOV was found in 20 (33%) patients and GB-SV in 41 (67%). Forms of SV that affected the GB were PAN (n ¼ 10), 4,12,22,32,38,45,46,51,54 HBV-associated vasculitis (n ¼ 8), 10,11,17,38,46,56,60 cryoglobulinemic (essential or HCVassociated) vasculitis (n ¼ 6), 9,14,19,36,50 MPA (n ¼ 4), 5,31,38,40 EGPA (Churg-Strauss) (n ¼ 4), 20,43,48,61 IgA vasculitis (Henoch-Schönlein) (n ¼ 2), 23,28 giant cell arteritis (n ¼ 1), 47 and vasculitis associated with autoimmune diseases (n ¼ 6) 11,16,18,42,58 (see Table 4). Systemic diseases with associated vasculitis included RA (n ¼ 3), 11,16,18 SLE (n ¼ 2), 42,58 and systemic sclerosis (n ¼ 1).…”
Section: Overall Resultsmentioning
confidence: 99%
See 3 more Smart Citations